IGNAZ trial interim results highlight HI-Bio’s potential to differentiate in IgAN space: GlobalData

Read more

DoP orders pharma cos to comply to self-declaration under UPCMP 2024

Read more

Biogen receives EC approval for QALSODY to treat rare genetic form of ALS

Read more

Parse Biosciences launches data analysis platform Trailmaker

Read more

iBRIC organises 2nd THSTI advanced course in vaccinology

Read more

JJP Biologics to execute in-human clinical trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

Read more

Neurology remains key therapeutic area for Japan pharma majors: GlobalData

Read more

Alembic announces USFDA approval for Sacubitril and Valsartan tablets

Read more

Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication

Read more

Merck KGaA announces its largest investment in Asia

Read more